TABLE 2.
Inhibitor and protease variant | Ka (M−1) | Kd (nM) | Kd ratio | ΔH (kcal mol−1) | ΔΔH | −TΔS (kcal mol−1) | Δ(−TΔS) | ΔG (kcal mol−1) | ΔΔG |
---|---|---|---|---|---|---|---|---|---|
NFV | |||||||||
B-WT | (2.6 ± 0.5) × 109 | 0.39 ± 0.07 | 1.0 | 4.4 ± 0.1 | −17.0 | −12.6 ± 0.1 | |||
B-D30N/N88D | (1.2 ± 0.4) × 108 | 8.1 ± 2.8 | 20.7 | 6.7 ± 0.3 | 2.3 | −17.5 | 0.5 | −10.8 ± 0.2 | 1.8 |
AE-WT | (3.7 ± 1.0) × 108 | 2.7 ± 0.7 | 6.9 | 5.0 ± 0.3 | 0.6 | −16.6 | 0.9 | −11.5 ± 0.2 | 1.1 |
AE-N88S | (5.8 ± 1.2) × 107 | 17.2 ± 3.5 | 44.1 | 6.2 ± 0.7 | 1.8 | −16.6 | 0.9 | −10.4 ± 0.1 | 2.2 |
DRV | |||||||||
B-WT | (2.2 ± 1.1) × 1011 | 0.004 ± 0.002 | 1.0 | −12.1 ± 0.9 | −3.1 | −15.2 ± 0.3 | |||
B-D30N/N88D | (3.7 ± 0.7) × 1010 | 0.026 ± 0.005 | 6.5 | −12.5 ± 0.4 | −0.4 | −1.6 | 1.5 | −14.2 ± 0.1 | 1.0 |
AE-WT | (9.1 ± 0.3) × 1010 | 0.0109 ± 0.0003 | 2.7 | −10.1 ± 0.5 | 2.0 | −4.6 | −1.5 | −14.7 ± 0.02 | 0.5 |
AE-N88S | (1.1 ± 0.8) × 1010 | 0.087 ± 0.062 | 21.8 | −5.1 ± 3.6 | 7.0 | −8.4 | −5.3 | −13.5 ± 0.4 | 1.7 |
APV | |||||||||
B-WT | (2.6 ± 1.3) × 109 | 0.39 ± 0.20 | 1.0 | −7.3 ± 0.9 | −5.3 | −12.6 ± 0.3 | |||
B-D30N/N88D | (1.2 ± 0.2) × 1010 | 0.08 ± 0.01 | 0.2 | −10.2 ± 1.5 | −2.9 | −3.3 | 2.0 | −13.5 ± 0.09 | −0.9 |
AE-WT | (3.1 ± 0.2) × 109 | 0.32 ± 0.02 | 0.8 | −5.5 ± 0.3 | −1.8 | −7.3 | −2.0 | −12.70 ± 0.03 | −0.1 |
AE-N88S | (1.3 ± 0.9) × 1010 | 0.08 ± 0.06 | 0.2 | −5.0 ± 3.6 | 2.3 | −8.6 | −3.3 | −13.6 ± 0.4 | −1.0 |
Ka, association constant; Kd, dissociation constant; H, enthalpy; T, temperature; S, entropy; G, Gibbs free energy.